QVT Financial LP sold $49.4M of Roivant Sciences (ROIV)

Executed Jun 26, disclosed Jun 30, 4 days later.

Value, as filed

$49.4M

1,438,163 sh across 5 lots

Executed

Jun 26

the trade date, as filed

Disclosed

Jun 30

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

QL QVT Financial LP Other profile →

QVT Financial LP (Other) filed 5 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 5 sales), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $49.4M of ROIV (1,438,163 sh across 5 lots, as filed), executed Jun 26.

The name

ROIV

Roivant Sciences Ltd. ROIV · Healthcare · 75 filings in 24 months ticker →

Healthcare · Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicine…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by QVT Financial LP in ROIV

ROIVSALE Roivant Sciences Ltd. $32.7M
1,225,784 sh across 5 lots
Exec Feb 11
Filed Feb 13 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $39.1M
1,694,614 sh across 5 lots
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $26.3M
1,300,000 sh across 4 lots
Exec Nov 19 2025
Filed Nov 21 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. $10.9M
926,000 sh across 2 lots
Exec Sep 25 2024
Filed Sep 26 2024 · 5:30 PM ET